SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-17-041865
Filing Date
2017-11-09
Accepted
2017-11-09 16:57:04
Documents
44
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 513866
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 9315
3 EXHIBIT 31 ex31.htm EX-31 11991
4 EXHIBIT 32 ex32.htm EX-32 5551
11 image00001.jpg GRAPHIC 13310
  Complete submission text file 0001140361-17-041865.txt   3307537

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bstc-20170930.xml EX-101.INS 589868
6 XBRL TAXONOMY EXTENSION SCHEMA bstc-20170930.xsd EX-101.SCH 28721
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bstc-20170930_cal.xml EX-101.CAL 36715
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bstc-20170930_def.xml EX-101.DEF 120834
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20170930_lab.xml EX-101.LAB 437966
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20170930_pre.xml EX-101.PRE 242173
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 171191659
SIC: 2834 Pharmaceutical Preparations